Good outcomes in babies with in-utero bedaquiline exposure.

[1]  T. Reddy,et al.  Maternal and Infant Outcomes Among Pregnant Women Treated for Multidrug/Rifampicin-Resistant Tuberculosis in South Africa , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Alimuddin Zumla,et al.  Tuberculosis in children, adolescents, and women. , 2020, The Lancet Respiratory Medicine.

[3]  J. Bruchfeld,et al.  Increased risk of active tuberculosis during pregnancy and postpartum: a register-based cohort study in Sweden , 2019, European Respiratory Journal.

[4]  V. Sintchenko,et al.  Community-wide Screening for Tuberculosis in a High-Prevalence Setting. , 2019, The New England journal of medicine.

[5]  M. Hughes,et al.  Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons , 2019, PLoS medicine.

[6]  R. Schinazi,et al.  Potential drug–drug interactions between antiretroviral therapy and treatment regimens for multi-drug resistant tuberculosis: Implications for HIV care of MDR-TB co-infected individuals , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[7]  M. Kruijshaar,et al.  Risk of tuberculosis in pregnancy: a national, primary care-based cohort and self-controlled case series study. , 2012, American journal of respiratory and critical care medicine.

[8]  P. Goussard,et al.  Nosocomial transmission of Mycobacterium tuberculosis in kangaroo mother care units: a risk in tuberculosis-endemic areas. , 2006 .